Latest Updates
-
How to Open a Savings Account Online in India: A Step-by-Step Guide -
OTT Releases This Week (3rd Aug to 9th Aug): What To Stream On Netflix, Prime, JioHotstar, Zee5, and SonyLiv -
What New Mothers Should Eat While Breastfeeding, According to an Expert -
When Is Hariyali Teej 2026? Date, Shubh Muhurat, and Full Puja Vidhi -
Half of India's Infertility Cases Trace Back to Men — Few Get Tested -
World Breastfeeding Week 2026: Breastfeeding During Fever, Cough And Cold — Should Mothers Continue? -
Usha Nadkarni Reveals Her Biggest Fear About Living Alone At 80 -
World Breastfeeding Week 2026: Beyond The First Feed—Why Early Support Matters For Mother And Baby -
The Mental Health Side Of Breastfeeding No One Really Talks About: What An Expert Wants You To Know -
Who Is Shreya Kalra? Meet The Lock Upp Season 2 Winner Who Took Home ₹1 Crore, Beating Shivangi Joshi
Anti-parasitic Drug Can Kill COVID-19 Cell Culture Within 48 Hours, Study Finds
The race to develop a treatment for the novel coronavirus (COVID-19) is in full swing. While researchers all around the world are testing the existing drugs against COVID-19, Australian scientists have found a common anti-parasitic drug that killed SARS-CoV-2 growing in cell culture within 48 hours.
The anti-parasitic drug ivermectin is an FDA-approved drug that has been shown to be effective in vitro against many viruses including dengue, HIV, influenza and Zika virus.

The study published in the journal Antiviral Research showed that the drug ivermectin stopped the coronavirus from growing in cell culture within 48 hours [1].
Studies on SARS-CoV proteins have found an important role for IMPα/β1 during infection in signal-dependent nucleocytoplasmic inhibiting the SARS-CoVNucleocapsid protein that may impact host cell division.
Dr Kylie Wagstaff, the study's lead author said, "We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it".

Ivermectin reduced SARS-CoV-2 viral RNA present in the cell culture by 93 per cent after 24 hours and after 48 hours it got reduced by 99.8 per cent.
However, Dr Kylie Wagstaff cautioned that the tests were carried out in vitro and further testing and clinical trials carried out in humans would be needed to see if the drug is effective against coronavirus. She said, "Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective - that's the next step,".
She further said that,"In times when we're having a global pandemic and there isn't an approved treatment, if we had a compound that was already available around the world then that might help people sooner. Realistically it's going to be a while before a vaccine is broadly available".
The collaborative study was led by the Monash Biomedicine Discovery Institute and the Peter Doherty Institute of Infection and Immunity.

What Is The Current Scenario Of Coronavirus Cases?
COVID-19 has infected 1,275, 856 people and caused 69, 514 deaths worldwide. In India, the total number of coronavirus cases has crossed the 4,000 mark with the death toll crossing 100.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications